Wyniki wyszukiwania:

There are 7,000 rare diseases affecting 6%-8% of the global population. That's 3.5 million people in the UK alone. Yet only 200 rare diseases have approved treatments. In recent years, there has been a surge of interest from business and social entrepreneurs in the field of health - including looking at ways to treat rare disease patients better and faster.

An analysis of the production and consumption of the communications of Make Poverty History, a high profile episode of social movement protest in the UK. The book follows the campaign throughout its lifetime and explores how attitudes towards government and political opportunities influenced the negotiation of communications.

It is increasingly clear that 50 years of international development have done little to reduce poverty in Africa. Indeed, more and more academics and practitioners are highlighting the detrimental effect of traditional development - as carried out by international agencies and NGOs - which often leads to dependency, inefficiency, waste and poor governance.

An analysis of the production and consumption of the communications of Make Poverty History, a high profile episode of social movement protest in the UK. The book follows the campaign throughout its lifetime and explores how attitudes towards government and political opportunities influenced the negotiation of communications.

This new book edited by rare disease experts Anthony Hall and Nicolas Sireau provides a collection of chapters by world leaders in the field of orphan diseases and drugs in order to help patient groups grow fast and sustainably. As a practical, hands-on guide for research and drug development, it provides tools and advice on topics such as: - How to set up and manage a patient group: US and UK perspectives. - How to build an international research consortium. - How to promote basic research. - How to engage with academia for drug discovery. - How to engage with industry. - How to set up a...